Biotech Values

[DewDiligence]

PTLA’s presentation at the WF conference contained more than a modicum of spin, IMO, on the positioning of Betrixaban. I also think the phase-3 trial of Betrixaban for VTE prevention in acute hospitalized patients (http://www.clinicaltrials.gov/ct2/show/NCT01583218 ) is rigged.